Life Science Start-Ups: Venture Funding, September 2014
• By Deanna Kamienski, Beth Allan, Amanda Micklus, and Maureen Riordan
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding column provides a comprehensive monthly review of emerging life science companies that have received VC funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced June through August 2014.
Series C brings $30mm to Epic Sciences
Epic Sciences Inc. (molecular diagnostics for cancer) closed a $30mm Series C round. New investors RusnanoMedInvest and Arcus Ventures...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
